Sandoz Pharmaceuticals AG - Estalis 50/140, transdermale Pflaster |
| 54704 | | 01 | | Estalis 50/140 | | transdermale Pflaster | | G03FA01 | | Norethisterone and Estrogen | | 17.08.1999 | | |
|
Composition |
estradiolum 0.60 mg ut estradiolum hemihydricum 0.62 mg, norethisteroni acetas 2.7 mg, silicone adhesive, acrylic adhesive, povidonum K 30, acidum oleicum, dipropylenglycolum, Trägermaterial: ad praeparationem pro 9 cm², cum liberatione 50 µg et 140 µg/24 h. |
Packungsbestandteile |
| Transdermal patch | | | Active Agent | Dose |
---|
Estradiol | 0.6 mg | Norethisterone Acetate | 2.7 mg |
| BAG: Active Agent | Dose |
---|
Estradiol | 0.6 mg | Norethisterone Acetate | 2.7 mg |
| | Inactive agents | Dose | additional_information |
---|
Acidum Oleicum | | | Acrylic Adhesive | | | Ad Praeparationem | 9 cm | Trägermaterial | Cum Liberatione | 50µg et 140 µg / 24h | | Dipropylenglycol | | | Povidonum K | 30 | | Silicone Adhesive | | |
| |
|
|